Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act, 35309-35310 [2021-14251]

Download as PDF Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices biology, computational toxicology, neurotoxicology, genetic toxicology, reproductive toxicology or teratology, and biostatistics. Members serve overlapping terms of up to four years. The BSC usually meets periodically. The authority for the BSC is provided by 42 U.S.C. 217a, section 222 of the Public Health Service Act (PHS), as amended. The BSC is governed by the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C. app.), which sets forth standards for the formation and use of advisory committees. [FR Doc. 2021–14222 Filed 7–1–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID FEMA–2020–0016] Dated: June 29, 2021. Brian R. Berridge, Associate Director, National Toxicology Program. Meetings To Implement Pandemic Response Voluntary Agreement Under Section 708 of the Defense Production Act [FR Doc. 2021–14238 Filed 7–1–21; 8:45 am] AGENCY: Federal Emergency Management Agency, Department of Homeland Security. ACTION: Announcement of meetings. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; From Genomic Association to Causation: A Convergent Neuroscience Approach for Neuropsychiatric Disorders (U19). Date: July 28, 2021. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: David W. Miller, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–9734, millerda@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) VerDate Sep<11>2014 17:12 Jul 01, 2021 Jkt 253001 The Federal Emergency Management Agency (FEMA) is holding a series of meetings to implement the Voluntary Agreement for the Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic. DATES: The schedule for these meetings is as follows: • The first meeting took place on Tuesday, June 22, 2021, from 2 to 4 p.m. Eastern Time (ET). • The second meeting took place on Wednesday, June 23, 2021, from 11 a.m. to 1 p.m. ET. • The third meeting took place on Tuesday, June 29, 2021, from 2 to 4 p.m. ET. • The fourth meeting took place on Thursday, July 1, 2021, from 2 to 4 p.m. ET. • The fifth meeting will take place on Tuesday, July 20, 2021, from 11 a.m. to 1 p.m. ET. • The sixth meeting will take place on Thursday, July 22, 2021, from 2 to 4 p.m. ET. • The seventh meeting will take place on Tuesday, August 3, 2021, from 11 a.m. to 1 p.m. ET. • The eighth meeting will take place on Thursday, August 5, 2021, from 2 to 4 p.m. ET. FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, Industry, Infrastructure Integration, via email at OB3I@fema.dhs.gov or via phone at (202) 212–1666. SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as required by section 708(h)(8) of the Defense Production Act (DPA), 50 U.S.C. 4558(h)(8), and consistent with 44 CFR part 332. SUMMARY: National Institutes of Health lotter on DSK11XQN23PROD with NOTICES1 Dated: June 29, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 35309 The DPA authorizes the making of ‘‘voluntary agreements and plans of action’’ with representatives of industry, business, and other interests to help provide for the national defense.1 The President’s authority to facilitate voluntary agreements with respect to responding to the spread of COVID–19 within the United States was delegated to the Secretary of Homeland Security in Executive Order 13911.2 The Secretary of Homeland Security further delegated this authority to the FEMA Administrator.3 On August 17, 2020, after the appropriate consultations with the Attorney General and the Chairman of the Federal Trade Commission, FEMA completed and published in the Federal Register a ‘‘Voluntary Agreement, Manufacture and Distribution of Critical Healthcare Resources Necessary to Respond to a Pandemic’’ (Voluntary Agreement).4 Unless terminated earlier, the Voluntary Agreement is effective until August 17, 2025, and may be extended subject to additional approval by the Attorney General after consultation with the Chairman of the Federal Trade Commission. The Agreement may be used to prepare for or respond to any pandemic, including COVID–19, during that time. On December 7, 2020, the first plan of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Personal Protective Equipment (PPE) to Respond to COVID– 19 (PPE Plan of Action)—was finalized.5 The PPE Plan of Action established several sub-committees under the Voluntary Agreement, focusing on different aspects of the PPE Plan of Action. On May 24, 2021, four additional plans of action under the Voluntary Agreement—the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Diagnostic Test Kits and other Testing Components to respond to COVID–19, the Plan of Action to 1 50 U.S.C. 4558(c)(1). FR 18403 (Apr. 1, 2020). 3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS Delegation Number 09052 Rev. 00 (Jan. 3, 2017). 4 85 FR 50035 (Aug. 17, 2020). The Attorney General, in consultation with the Chairman of the Federal Trade Commission, made the required finding that the purpose of the voluntary agreement may not reasonably be achieved through an agreement having less anticompetitive effects or without any voluntary agreement and published the finding in the Federal Register on the same day. 85 FR 50049 (Aug. 17, 2020). 5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 8, 2020). 2 85 E:\FR\FM\02JYN1.SGM 02JYN1 35310 Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices lotter on DSK11XQN23PROD with NOTICES1 Establish a National Strategy for the Manufacture, Allocation, and Distribution of Drug Products, Drug Substances, and Associated Medical Devices to respond to COVID–19, the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Medical Devices to respond to COVID–19, and the Plan of Action to Establish a National Strategy for the Manufacture, Allocation, and Distribution of Medical Gases to respond to COVID–19—were finalized.6 These plans of action established several sub-committees under the Voluntary Agreement, focusing on different aspects of each plan of action. The meetings are chaired by the FEMA Administrator or her delegate and attended by the Attorney General and the Chairman of the Federal Trade Commission or their delegates. In implementing the Voluntary Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 4558 and 44 CFR part 332. Meeting Objectives: The objectives of the meetings are as follows: 1. Gather committee Participants and Attendees to ask targeted questions for situational awareness about PPE, drug products and drug substances, diagnostic test kits, medical devices, and medical gases. 2. Establish priorities for COVID–19 response under the Voluntary Agreement. 3. Identify tasks that should be completed under the appropriate SubCommittee. 4. Identify information gaps and areas that merit sharing (both from FEMA to the private sector and vice versa). Meetings Closed to the Public: By default, the DPA requires meetings held to implement a voluntary agreement or plan of action be open to the public.7 However, attendance may be limited if the Sponsor 8 of the voluntary agreement finds that the matter to be discussed at a meeting falls within the purview of matters described in 5 U.S.C. 552b(c), such as trade secrets and commercial or financial information. The Sponsor of the Voluntary Agreement, the FEMA Administrator, found that these meetings to implement the Voluntary Agreement involve matters which fall within the purview of matters described in 5 U.S.C. 552b(c) and the meetings are therefore closed to the public. Specifically, these meetings to implement the Voluntary Agreement may require participants to disclose trade secrets or commercial or financial information that is privileged or confidential. Disclosure of such information allows for meetings to be closed pursuant to 5 U.S.C. 552b(c)(4). In addition, the success of the Voluntary Agreement depends wholly on the willing and enthusiastic participation of private sector participants. Failure to close these meetings could have a strong chilling effect on private sector participation and cause a substantial risk that sensitive information will be prematurely released to the public, leading to participants withdrawing their support from the Voluntary Agreement. This would significantly frustrate the implementation of the Voluntary Agreement. Frustration of an agency’s objective due to premature disclosure of information allows for the closure of a meeting pursuant to 5 U.S.C. 552b(c)(9)(B). [FR Doc. 2021–14251 Filed 7–1–21; 8:45 am] Officer, QDAM, Department of Housing and Urban Development, 451 7th Street SW, Room 4176, Washington, DC 20410–5000; telephone 202–402–3400 (this is not a toll-free number) or email at Colette.Pollard@hud.gov for a copy of the proposed forms or other available information. Persons with hearing or speech impairments may access this number through TTY by calling the tollfree Federal Relay Service at (800) 877– 8339. FOR FURTHER INFORMATION CONTACT: Colette Pollard, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 7th Street SW, Washington, DC 20410; email Colette Pollard at Colette.Pollard@ hud.gov or telephone 202–402–3400. This is not a toll-free number. Persons with hearing or speech impairments may access this number through TTY by calling the toll-free Federal Relay Service at (800) 877–8339. Copies of available documents submitted to OMB may be obtained from Ms. Pollard. SUPPLEMENTARY INFORMATION: This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. BILLING CODE 9111–19–P A. Overview of Information Collection Deanne Criswell, Administrator, Federal Emergency Management Agency. DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7038–N–09] 60-Day Notice of Proposed Information Collection: FHA Catalyst: Multifamily Application Portal, OMB Control No.: 2502–0620 Office of the Assistant Secretary for Housing—Federal Housing Commissioner, HUD. ACTION: Notice. AGENCY: HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 60 days of public comment. SUMMARY: DATES: Comments Due Date: August 31, 2021. 6 See 86 FR 27894 (May 24, 2021). See also 86 FR 28851 (May 28, 2021). 7 See 50 U.S.C. 4558(h)(7). 8 ‘‘[T]he individual designated by the President in subsection (c)(2) [of section 708 of the DPA] to administer the voluntary agreement, or plan of action.’’ 50 U.S.C. 4558(h)(7). VerDate Sep<11>2014 17:12 Jul 01, 2021 Jkt 253001 Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Control Number and should be sent to: Colette Pollard, Reports Management ADDRESSES: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Title of Information Collection: FHA Catalyst: Multifamily Application Portal. OMB Approval Number: 2502–0620. OMB Expiration Date: 5/31/2021. Type of Request: Extension of currently approved collection. Form Number: N/A. Description of the need for the information and proposed use: The Department of Housing and Urban Development (HUD)/Federal Housing Administration’s (FHA) Office of Multifamily Housing Programs (MFH) has developed a web-based portal for FHA-approved multifamily lenders to submit applications for FHA multifamily mortgage insurance to HUD electronically. The FHA Catalyst: Multifamily Application Portal (‘‘FHA Catalyst’’), was released in fall 2020 to aid in the collection of information for FHA multifamily mortgage insurance program applications. The National Housing Act (12 U.S.C. 1701 et seq.) and implementing regulations at 24 CFR parts 200–266 authorize HUD/FHA to administer the multifamily mortgage insurance programs. The specific authority to require a mortgage insurance application is found at 24 CFR 200.45(b): ‘‘[a]n application for a firm commitment must be made by an approved mortgagee for any project for E:\FR\FM\02JYN1.SGM 02JYN1

Agencies

[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35309-35310]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14251]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID FEMA-2020-0016]


Meetings To Implement Pandemic Response Voluntary Agreement Under 
Section 708 of the Defense Production Act

AGENCY: Federal Emergency Management Agency, Department of Homeland 
Security.

ACTION: Announcement of meetings.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) is holding a 
series of meetings to implement the Voluntary Agreement for the 
Manufacture and Distribution of Critical Healthcare Resources Necessary 
to Respond to a Pandemic.

DATES: The schedule for these meetings is as follows:
     The first meeting took place on Tuesday, June 22, 2021, 
from 2 to 4 p.m. Eastern Time (ET).
     The second meeting took place on Wednesday, June 23, 2021, 
from 11 a.m. to 1 p.m. ET.
     The third meeting took place on Tuesday, June 29, 2021, 
from 2 to 4 p.m. ET.
     The fourth meeting took place on Thursday, July 1, 2021, 
from 2 to 4 p.m. ET.
     The fifth meeting will take place on Tuesday, July 20, 
2021, from 11 a.m. to 1 p.m. ET.
     The sixth meeting will take place on Thursday, July 22, 
2021, from 2 to 4 p.m. ET.
     The seventh meeting will take place on Tuesday, August 3, 
2021, from 11 a.m. to 1 p.m. ET.
     The eighth meeting will take place on Thursday, August 5, 
2021, from 2 to 4 p.m. ET.

FOR FURTHER INFORMATION CONTACT: Robert Glenn, Office of Business, 
Industry, Infrastructure Integration, via email at [email protected] or 
via phone at (202) 212-1666.

SUPPLEMENTARY INFORMATION: Notice of these meetings is provided as 
required by section 708(h)(8) of the Defense Production Act (DPA), 50 
U.S.C. 4558(h)(8), and consistent with 44 CFR part 332.
    The DPA authorizes the making of ``voluntary agreements and plans 
of action'' with representatives of industry, business, and other 
interests to help provide for the national defense.\1\ The President's 
authority to facilitate voluntary agreements with respect to responding 
to the spread of COVID-19 within the United States was delegated to the 
Secretary of Homeland Security in Executive Order 13911.\2\ The 
Secretary of Homeland Security further delegated this authority to the 
FEMA Administrator.\3\
---------------------------------------------------------------------------

    \1\ 50 U.S.C. 4558(c)(1).
    \2\ 85 FR 18403 (Apr. 1, 2020).
    \3\ DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); DHS 
Delegation Number 09052 Rev. 00 (Jan. 3, 2017).
---------------------------------------------------------------------------

    On August 17, 2020, after the appropriate consultations with the 
Attorney General and the Chairman of the Federal Trade Commission, FEMA 
completed and published in the Federal Register a ``Voluntary 
Agreement, Manufacture and Distribution of Critical Healthcare 
Resources Necessary to Respond to a Pandemic'' (Voluntary 
Agreement).\4\ Unless terminated earlier, the Voluntary Agreement is 
effective until August 17, 2025, and may be extended subject to 
additional approval by the Attorney General after consultation with the 
Chairman of the Federal Trade Commission. The Agreement may be used to 
prepare for or respond to any pandemic, including COVID-19, during that 
time.
---------------------------------------------------------------------------

    \4\ 85 FR 50035 (Aug. 17, 2020). The Attorney General, in 
consultation with the Chairman of the Federal Trade Commission, made 
the required finding that the purpose of the voluntary agreement may 
not reasonably be achieved through an agreement having less 
anticompetitive effects or without any voluntary agreement and 
published the finding in the Federal Register on the same day. 85 FR 
50049 (Aug. 17, 2020).
---------------------------------------------------------------------------

    On December 7, 2020, the first plan of action under the Voluntary 
Agreement--the Plan of Action to Establish a National Strategy for the 
Manufacture, Allocation, and Distribution of Personal Protective 
Equipment (PPE) to Respond to COVID-19 (PPE Plan of Action)--was 
finalized.\5\ The PPE Plan of Action established several sub-committees 
under the Voluntary Agreement, focusing on different aspects of the PPE 
Plan of Action.
---------------------------------------------------------------------------

    \5\ See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 79020 (Dec. 
8, 2020).
---------------------------------------------------------------------------

    On May 24, 2021, four additional plans of action under the 
Voluntary Agreement--the Plan of Action to Establish a National 
Strategy for the Manufacture, Allocation, and Distribution of 
Diagnostic Test Kits and other Testing Components to respond to COVID-
19, the Plan of Action to

[[Page 35310]]

Establish a National Strategy for the Manufacture, Allocation, and 
Distribution of Drug Products, Drug Substances, and Associated Medical 
Devices to respond to COVID-19, the Plan of Action to Establish a 
National Strategy for the Manufacture, Allocation, and Distribution of 
Medical Devices to respond to COVID-19, and the Plan of Action to 
Establish a National Strategy for the Manufacture, Allocation, and 
Distribution of Medical Gases to respond to COVID-19--were 
finalized.\6\ These plans of action established several sub-committees 
under the Voluntary Agreement, focusing on different aspects of each 
plan of action.
---------------------------------------------------------------------------

    \6\ See 86 FR 27894 (May 24, 2021). See also 86 FR 28851 (May 
28, 2021).
---------------------------------------------------------------------------

    The meetings are chaired by the FEMA Administrator or her delegate 
and attended by the Attorney General and the Chairman of the Federal 
Trade Commission or their delegates. In implementing the Voluntary 
Agreement, FEMA adheres to all procedural requirements of 50 U.S.C. 
4558 and 44 CFR part 332.
    Meeting Objectives: The objectives of the meetings are as follows:
    1. Gather committee Participants and Attendees to ask targeted 
questions for situational awareness about PPE, drug products and drug 
substances, diagnostic test kits, medical devices, and medical gases.
    2. Establish priorities for COVID-19 response under the Voluntary 
Agreement.
    3. Identify tasks that should be completed under the appropriate 
Sub-Committee.
    4. Identify information gaps and areas that merit sharing (both 
from FEMA to the private sector and vice versa).
    Meetings Closed to the Public: By default, the DPA requires 
meetings held to implement a voluntary agreement or plan of action be 
open to the public.\7\ However, attendance may be limited if the 
Sponsor \8\ of the voluntary agreement finds that the matter to be 
discussed at a meeting falls within the purview of matters described in 
5 U.S.C. 552b(c), such as trade secrets and commercial or financial 
information. The Sponsor of the Voluntary Agreement, the FEMA 
Administrator, found that these meetings to implement the Voluntary 
Agreement involve matters which fall within the purview of matters 
described in 5 U.S.C. 552b(c) and the meetings are therefore closed to 
the public.
---------------------------------------------------------------------------

    \7\ See 50 U.S.C. 4558(h)(7).
    \8\ ``[T]he individual designated by the President in subsection 
(c)(2) [of section 708 of the DPA] to administer the voluntary 
agreement, or plan of action.'' 50 U.S.C. 4558(h)(7).
---------------------------------------------------------------------------

    Specifically, these meetings to implement the Voluntary Agreement 
may require participants to disclose trade secrets or commercial or 
financial information that is privileged or confidential. Disclosure of 
such information allows for meetings to be closed pursuant to 5 U.S.C. 
552b(c)(4). In addition, the success of the Voluntary Agreement depends 
wholly on the willing and enthusiastic participation of private sector 
participants. Failure to close these meetings could have a strong 
chilling effect on private sector participation and cause a substantial 
risk that sensitive information will be prematurely released to the 
public, leading to participants withdrawing their support from the 
Voluntary Agreement. This would significantly frustrate the 
implementation of the Voluntary Agreement. Frustration of an agency's 
objective due to premature disclosure of information allows for the 
closure of a meeting pursuant to 5 U.S.C. 552b(c)(9)(B).

Deanne Criswell,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2021-14251 Filed 7-1-21; 8:45 am]
BILLING CODE 9111-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.